Literature DB >> 19276229

Polymorphisms of the scavenger receptor class B member 1 are associated with insulin resistance with evidence of gene by sex interaction.

Jeanette J McCarthy1, Aleefia Somji, Lauren A Weiss, Brian Steffy, Raquel Vega, Elizabeth Barrett-Connor, Gregory Talavera, Richard Glynne.   

Abstract

BACKGROUND: Genetic variation in diabetes-associated genes cumulatively explain little of the overall heritability of this trait. We sought to determine whether polymorphisms of the scavenger receptor class B, member I (SCARB1), an estrogen-regulated chromosome 12q24 positional candidate diabetes gene, were associated with type 2 diabetes or insulin resistance in a sex-specific fashion.
METHODS: We evaluated 34 haplotype-tagged single-nucleotide polymorphisms (SNPs) of SCARB1 for their association with type 2 diabetes and measures of insulin resistance in two populations: a clinic-based sample of 444 Mexican-American women from Proyecto SALSA and a community-based sample of 830 white women from the Rancho Bernardo Study.
RESULTS: We identified significant associations between a tagged SNP in intron 9, rs9919713, and fasting glucose in the SALSA population (P = 2.3 x 10(-4)). In the Rancho Bernardo Study, the same SNP also showed significant association with the related traits homeostasis model assessment for insulin resistance (P = 3.0 x 10(-4)), fasting glucose (P = 1.1 x 10(-3)), and type 2 diabetes (P = 9.0 x 10(-3)). In men from the Rancho Bernardo population, the opposite effect was found (genotype by sex interaction in the Rancho Bernardo population P < 10(-3) for insulin resistance).
CONCLUSIONS: Our data support an association between SCARB1 variants and insulin resistance, especially in women, with evidence of significant gene by sex interaction. These findings warrant further investigation in additional populations and prompt exploration of a role for SR-BI in the development of insulin resistance.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19276229      PMCID: PMC2684479          DOI: 10.1210/jc.2008-2800

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  31 in total

1.  Quantitative trait loci for abdominal fat and BMI in Hispanic-Americans and African-Americans: the IRAS Family study.

Authors:  J M Norris; C D Langefeld; A L Scherzinger; S S Rich; E Bookman; S R Beck; M F Saad; S M Haffner; R N Bergman; D W Bowden; L E Wagenknecht
Journal:  Int J Obes (Lond)       Date:  2005-01       Impact factor: 5.095

2.  Linkage and potential association of obesity-related phenotypes with two genes on chromosome 12q24 in a female dizygous twin cohort.

Authors:  Scott G Wilson; Gail Adam; Maria Langdown; Rikard Reneland; Andreas Braun; Toby Andrew; Gabriela L Surdulescu; Maria Norberg; Frank Dudbridge; Peter W Reed; Philip N Sambrook; Patrick W Kleyn; Tim D Spector
Journal:  Eur J Hum Genet       Date:  2006-03       Impact factor: 4.246

3.  Variants in the CD36 gene associate with the metabolic syndrome and high-density lipoprotein cholesterol.

Authors:  Latisha Love-Gregory; Richard Sherva; Lingwei Sun; Jon Wasson; Timothy Schappe; Alessandro Doria; D C Rao; Steven C Hunt; Samuel Klein; Rosalind J Neuman; M Alan Permutt; Nada A Abumrad
Journal:  Hum Mol Genet       Date:  2008-02-27       Impact factor: 6.150

4.  Personal genomes: The case of the missing heritability.

Authors:  Brendan Maher
Journal:  Nature       Date:  2008-11-06       Impact factor: 49.962

5.  The fatty acid transporter FAT/CD36 is upregulated in subcutaneous and visceral adipose tissues in human obesity and type 2 diabetes.

Authors:  A Bonen; N N Tandon; J F C Glatz; J J F P Luiken; G J F Heigenhauser
Journal:  Int J Obes (Lond)       Date:  2006-06       Impact factor: 5.095

6.  Differences between respondents and non-respondents in a population-based cardiovascular disease study.

Authors:  M H Criqui; E Barrett-Connor; M Austin
Journal:  Am J Epidemiol       Date:  1978-11       Impact factor: 4.897

7.  Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels.

Authors:  K F Kozarsky; M H Donahee; A Rigotti; S N Iqbal; E R Edelman; M Krieger
Journal:  Nature       Date:  1997-05-22       Impact factor: 49.962

8.  Scavenger receptor BI facilitates the metabolism of VLDL lipoproteins in vivo.

Authors:  Miranda Van Eck; Menno Hoekstra; Ruud Out; I Sophie T Bos; J Kar Kruijt; Reeni B Hildebrand; Theo J C Van Berkel
Journal:  J Lipid Res       Date:  2007-10-22       Impact factor: 5.922

9.  Family History of Diabetes, Acculturation, and the Metabolic Syndrome among Mexican Americans: Proyecto SALSA.

Authors:  Tamara Nelson; Angelica Perez; John Alcaraz; Gregory Talavera; Jeanette J McCarthy
Journal:  Metab Syndr Relat Disord       Date:  2007-09       Impact factor: 1.894

10.  Nuclear receptor corepressors and PPARgamma.

Authors:  Ronald N Cohen
Journal:  Nucl Recept Signal       Date:  2006-02-08
View more
  10 in total

1.  Gene Networks of Hyperglycemia, Diabetic Complications, and Human Proteins Targeted by SARS-CoV-2: What Is the Molecular Basis for Comorbidity?

Authors:  Olga V Saik; Vadim V Klimontov
Journal:  Int J Mol Sci       Date:  2022-06-29       Impact factor: 6.208

2.  Genome-wide association study identifies common variants associated with circulating vitamin E levels.

Authors:  Jacqueline M Major; Kai Yu; William Wheeler; Hong Zhang; Marilyn C Cornelis; Margaret E Wright; Meredith Yeager; Kirk Snyder; Stephanie J Weinstein; Alison Mondul; Heather Eliassen; Mark Purdue; Aditi Hazra; Catherine A McCarty; Sara Hendrickson; Jarmo Virtamo; David Hunter; Stephen Chanock; Peter Kraft; Demetrius Albanes
Journal:  Hum Mol Genet       Date:  2011-07-05       Impact factor: 6.150

3.  Genome-wide association study identifies two novel Loci with sex-specific effects for type 2 diabetes mellitus and glycemic traits in a korean population.

Authors:  Min Jin Go; Joo-Yeon Hwang; Tae-Joon Park; Young Jin Kim; Ji Hee Oh; Yeon-Jung Kim; Bok-Ghee Han; Bong-Jo Kim
Journal:  Diabetes Metab J       Date:  2014-10-17       Impact factor: 5.376

Review 4.  Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus.

Authors:  Alexandra Kautzky-Willer; Jürgen Harreiter; Giovanni Pacini
Journal:  Endocr Rev       Date:  2016-05-09       Impact factor: 19.871

5.  Polymorphisms of lipid metabolism enzyme-coding genes in patients with diabetic dyslipidemia.

Authors:  Aslı Tetik Vardarlı; Ece Harman; Vildan Bozok Çetintaş; Meral Kayıkçıoğlu; Egemen Vardarlı; Ayhan Zengi; Ali Şahin Küçükaslan; Zuhal Eroğlu
Journal:  Anatol J Cardiol       Date:  2017-03-03       Impact factor: 1.596

6.  Expression Levels and Genetic Polymorphism of Scavenger Receptor Class B Type 1 as a Biomarker of Type 2 Diabetes Mellitus.

Authors:  Mohd Wamique; D Himanshu; Wahid Ali
Journal:  Sultan Qaboos Univ Med J       Date:  2022-02-28

7.  Investigation of genetic variation in scavenger receptor class B, member 1 (SCARB1) and association with serum carotenoids.

Authors:  Gareth J McKay; Edward Loane; John M Nolan; Christopher C Patterson; Kristin J Meyers; Julie A Mares; Ekaterina Yonova-Doing; Christopher J Hammond; Stephen Beatty; Giuliana Silvestri
Journal:  Ophthalmology       Date:  2013-04-05       Impact factor: 12.079

8.  Mammalian NPC1 genes may undergo positive selection and human polymorphisms associate with type 2 diabetes.

Authors:  Nasser M Al-Daghri; Rachele Cagliani; Diego Forni; Majed S Alokail; Uberto Pozzoli; Khalid M Alkharfy; Shaun Sabico; Mario Clerici; Manuela Sironi
Journal:  BMC Med       Date:  2012-11-15       Impact factor: 8.775

Review 9.  SR-B1's Next Top Model: Structural Perspectives on the Functions of the HDL Receptor.

Authors:  Hayley R Powers; Daisy Sahoo
Journal:  Curr Atheroscler Rep       Date:  2022-02-02       Impact factor: 5.967

10.  Systematic review reveals multiple sexually antagonistic polymorphisms affecting human disease and complex traits.

Authors:  Jon Alexander Harper; Tim Janicke; Edward H Morrow
Journal:  Evolution       Date:  2021-11-12       Impact factor: 4.171

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.